• Không xem xét đến khả năng có bệnh thực thể tiềm tàng, đặc biệt ở những bệnh nhân có các triệu chứng không điển hình.
• Không nhận dạng được ý tưởng tự sát và/hoặc trầm cảm. Một nghiên cứu đã cho thấy bệnh nhân hội chứng ruột kích thích có thể có ý tưởng tự sát và/hoặc tìm cách tự sát vì các triệu chứng tiêu hoá tái diễn của họ. Cần cảnh giác về mặt lâm sàng để sớm phát hiện tình trạng trầm cảm và tuyệt vọng ở người bệnh. Điều này được nhấn mạnh trong một nghiên cứu khác cho thấy những than vãn liên tục về rối loạn chức năng tiêu hoá của bệnh nhân có thể bị tầm thường hóa.
Albatros Tham Khảo
1. Kassinen A, Krogius-Kurikka L, Mäkivuokko H, et al. The fecal microbiota of irritablebowel syndrome patients differs significantly from that of healthy subjects. bowel syndrome patients differs significantly from that of healthy subjects.
Gastroenterology. Jul 2007;133(1):24-33.
2. Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study. Am J Gastroenterol. Feb 2003;98(2):412-9.
3. Shepherd SJ, Parker FC, Muir JG, et al. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol. Jul 2008;6(7):765-71.
4. Miller V, Hopkins L, Whorwell PJ. Suicidal ideation in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. Dec 2004;2(12):1064-8. syndrome. Clin Gastroenterol Hepatol. Dec 2004;2(12):1064-8.
5. Camilleri M, McKinzie S, Busciglio I, et al. Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome. Clin psychologic, and autonomic functions in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. Jul 2008;6(7):772-81.
6. Cash BD, Chey WD. Advances in the management of irritable bowel syndrome. Curr Gastroenterol Rep. Dec 2003;5(6):468-75. Gastroenterol Rep. Dec 2003;5(6):468-75.
7. Dalton CB, Drossman DA, Hathaway JM, et al. Perceptions of physicians and patients with organic and functional gastrointestinal diagnoses. Clin Gastroenterol Hepatol. Feb with organic and functional gastrointestinal diagnoses. Clin Gastroenterol Hepatol. Feb 2004;2(2):121-6.
8. Dunlop SP, Jenkins D, Neal KR, et al. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology. Dec hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology. Dec 2003;125(6):1651-9.
9. Heitkemper MM, Jarrett ME, Levy RL, et al. Self-management for women with irritable bowel syndrome. Clin Gastroenterol Hepatol. Jul 2004;2(7):585-96. irritable bowel syndrome. Clin Gastroenterol Hepatol. Jul 2004;2(7):585-96.
study of lubiprostone in subjects with irritable bowel syndrome and constipation (constipation-predominant IBS). Gastroenterology. 2006;130:A-25 [Abstract 131]. 11. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. Apr 2006;130(5):1480-91.
12. Pimentel M, Park S, Mirocha J, et al. The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med. Oct 17 2006;145(8):557-63.
13. Salvioli B, Serra J, Azpiroz F, et al. Impaired small bowel gas propulsion in patients with bloating during intestinal lipid infusion. Am J Gastroenterol. Aug 2006;101(8):1853- with bloating during intestinal lipid infusion. Am J Gastroenterol. Aug 2006;101(8):1853- 7.
14. Sharara AI, Aoun E, Abdul-Baki H, et al. A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence. Am J controlled trial of rifaximin in patients with abdominal bloating and flatulence. Am J Gastroenterol. Feb 2006;101(2):326-33
15. Spiller RC. Postinfectious irritable bowel syndrome. Gastroenterology. May 2003;124(6):1662-71. 2003;124(6):1662-71.
16. Törnblom H, Lindberg G, Nyberg B, et al. Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. reveals inflammation and enteric neuropathy in irritable bowel syndrome.
Gastroenterology. Dec 2002;123(6):1972-9.
17. Hunt MG, Moshier S, Milonova M. Brief cognitive-behavioral internet therapy for irritable bowel syndrome. Behav Res Ther. Sep 2009;47(9):797-802. irritable bowel syndrome. Behav Res Ther. Sep 2009;47(9):797-802.
18. Reitblat T, Zamir D, Polishchuck I, et al. Patients treated by tegaserod for irritable bowel syndrome with constipation showed significant improvement in fibromyalgia bowel syndrome with constipation showed significant improvement in fibromyalgia symptoms. A pilot study. Clin Rheumatol. Sep 2009;28(9):1079-82.
19. Zijdenbos IL, de Wit NJ, van der Heijden GJ, Rubin G, Quartero AO. Psychological treatments for the management of irritable bowel syndrome. Cochrane Database Syst treatments for the management of irritable bowel syndrome. Cochrane Database Syst Rev. Jan 21 2009;CD006442.
20. Ford AC, Talley NJ, Schoenfeld PS, Quigley EM, Moayyedi P. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut. Mar 2009;58(3):367-78.